Description
FBC, PT, PTT, Antithrombin III, Factor V Leiden, (molecular DNA) Fibrinogen, Lupus Anticoagulant
Sample Type: Wholeblood, Serum, and Plasma
Tests Included:
This panel includes tests assessing specific factors related to thrombosis and blood clotting disorders, such as testing for protein C, protein S, antithrombin, and factor V Leiden mutation.
Sample Required:
Blood sample.
Test Time:
Results might be available within a few days to a week.
Test Range Values:
Results are compared to standard ranges for each specific coagulation factor measured.
What is the test?
The Coagulation 3 Thrombotic panel evaluates specific factors involved in thrombosis, assessing the risk of blood clotting disorders.
Test Procedure:
Blood is collected and analyzed in the laboratory for factors associated with thrombosis or abnormal clotting tendencies.
When to take the test:
This panel is ordered when there’s suspicion or family history of thrombotic disorders, unexplained blood clots, or recurrent clotting events.
Who should take the test:
Individuals with a personal or family history of blood clotting disorders, recurrent thrombotic events, or those requiring a more detailed assessment might require this panel.
Precautions for exceptional cases (if any):
Inform the healthcare provider about any ongoing medications or conditions that might affect blood clotting.
Frequently Asked Questions (FAQs) for Coagulation 3 Thrombotic:
Q1: What are protein C, protein S, and antithrombin?
A: These are natural anticoagulant proteins in the blood, crucial for regulating clotting processes.
Q2: Why is the factor V Leiden mutation tested in thrombotic panels?
A: Factor V Leiden mutation increases the risk of abnormal blood clotting, making individuals more susceptible to thrombosis.
Q3: Can this panel predict future clotting risks better than other coagulation tests?
A: It evaluates specific factors associated with thrombosis, aiding in assessing the risk of clotting disorders more comprehensively.
Q4: Can lifestyle changes affect the results?
A: Lifestyle factors can influence clotting tendencies, but this panel focuses on specific genetic or acquired factors related to thrombosis.
Q5: When should this test be repeated?
A: Repeated testing might be necessary for monitoring individuals with known clotting disorders or assessing ongoing risks.
*Please note that specific testing protocols and guidelines may vary based on the latest recommendations from health authorities and regulatory agencies. It is essential to consult healthcare professionals and follow local testing guidelines for accurate and appropriate testing.
